Exploring the Next Generation of Cancer Genomics at BSGM
News Sep 12, 2013
Oxford Gene Technology (OGT) is inviting delegates of the British Society for Genetic Medicine (BSGM) conference to join its seminar entitled “Genomic profiling of cancer - from aCGH to NGS” on Tuesday 17 September, 12.30-13.30.
Professor Bass Hassan, Professor of Medical Oncology at the University of Oxford, will be guest speaker at the seminar, where he will discuss his latest research: “Integrating NGS technology into a bench to bedside clinical programme in rare cancers”.
Professor Hassan is a close collaborator with OGT, whose expertise in genomic technologies is central to his research.
In a recent study working on the genomic characterization of a number of sarcoma cell lines, he benefited from OGT’s expertise in areas including targeted sequencing (exome and cancer panels), low-depth whole genome sequencing, RNA-Seq and aCGH.
As a “hot topic” in medical genetics, the seminar presents an ideal opportunity for researchers to hear more about the clinical application of NGS.
OGT’s microarray and sequencing products and services enable rapid access to meaningful, high-quality results. A range of cancer-specific options are available, including the SureSeq™ Solid Tumour Panel NGS Service and CytoSure arrays optimized for the rapid detection of CNV and LOH in haematological and solid tumours.
Delegates of BSGM conference can also visit booth 25, where they will not only have the chance to discuss how OGT can enhance their research, but can also enter into the prize draw to win an Amazon Kindle Fire Tablet.
In new studies a novel oxygen-delivery therapeutic restored the function of oxygen-starved heart tissue in an animal model of global hypoxia. Unlike its experimental predecessors, the new drug does not appear to cause systemic side effects or overcorrect with excessive blood oxygenation, which can itself be toxic. Instead, the new drug delivers its precious oxygen cargo only to the tissues that need it most.READ MORE